Isbister JP, Shander A, Spahn DR, Erhard J, Farmer SL, Hofmann A. Adverse blood transfusion outcomes: establishing causation. Transfus Med Rev 2011; 25(2): 89-101.
Guzzetta NA. Benefits and risks of red blood cell transfusion in pediatric patients undergoing cardiac surgery. Paediatr Anaesth 2011; 21(5): 504-11.
Khorana AA, Francis CW, Blumberg N, Culakova E, Refaai MA, Lyman GH. Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer. Archives of Intern Med 2008; 168(21): 2377-81.
Glance LG, Dick AW, Mukamel DB, Fleming FJ, Zollo RA, Wissler R, et al. Association between intraoperative blood transfusion and mortality and morbidity in patients undergoing noncardiac surgery. Anesthesiology 2011; 114(2): 283-92.
Goodnough LT, Levy JH, Murphy MF. Concepts of blood transfusion in adults. Lancet 2013; 381(9880): 1845-54.
Lavoie J. Blood transfusion risks and alternative strategies in pediatric patients. Paediatr Anaesth 2011; 21(1): 14-24.
Sahu S, Hemlata AV. Adverse events related to blood transfusion. Indian J Anaesth 2014; 58(5): 543-51.
Poole J, Daniels G. Blood group antibodies and their significance in transfusion medicine. Transfus Med Rev 2007; 21(1): 58-71.
Maxwell MJ, Wilson MJ. Complications of blood transfusion. Continuing Education in Anaesthesia, Critical Care & Pain 2006; 6(6): 225-9.
Nguyen DM, Lee HJ, Mirabella D, Wu DW. Delayed hemolytic transfusion reaction due to anti-Jkb: case report highlighting the importance of early blood bank consultation and literature review. N Am J Med Sci 2010; 3(4): 187-93.
Azarkeivan A, Ansari S, Ahmadi MH, Hajibeigy B, Maghsudlu M, Nasizadeh S, et al. Blood transfusion and alloimmunization in patients with thalassemia: multicenter study. Pediatr Hematol Oncol 2011; 28(6): 479-85.
Winters JL, Pineda AA, Gorden LD, Bryant SC, Melton III LJ, Vamvakas EC, et al. RBC alloantibody specificity and antigen potency in Olmsted County, Minnesota. Transfus. 2001;41(11):1413-20.
Ameen R, Al-Eyaadi O, Al-Shemmari S, Chowdhury R, Al-Bashir A. Frequency of red blood cell alloantibody in Kuwaiti population. Med Princ Pract. 2005;14(4):230-4.
Yousuf R, Aziz SA, Yusof N, Leong CF. Incidence of
red cell alloantibody among the transfusion recipients of Universiti Kebangsaan Malaysia Medical Centre. Indian J Hematol Blood Transfus. 2013 Jun 1;29(2):65-70.
Datta SS, Mukherjee S, Talukder B, Bhattacharya P, Mukherjee K. Frequency of red cell alloimmunization and autoimmunization in thalassemia patients: a report from Eastern India. Adv in Hematology. 2015;2015.
Babaei K, Esmaeilzadeh A, Asadi S, Sohrabi R. Prevalence of Red Blood Cell Alloantibodies in Blood Donors of Zanjan Province; the Preliminary Report of the North West of Iran. Biosci Biotech Res Asia. 2016 Dec 22;13(4):2207-10.
Gharehbaghian A, Ghezelbash B, Aghazade S, Hojjati MT. Evaluation of alloimmunization rate and necessity of blood type and screening test among patients candidate for elective surgery. Int J Hematol Oncol Stem Cell Res. 2014;8(1):1.
Reyhaneh K, Ahmad G, Gharib K, Vida V, Raheleh K, Mehdi TN. Frequency & specificity of RBC alloantibodies in patients due for surgery in Iran. The Indian J of Med Res. 2013 Aug;138(2):252.
Keikhaei B, Far AH, Abolghasemi H, Mousakhani H, Ghanavat M, Moghadam M. Red blood cell alloimmunization in patients with thalassemia major and intermediate in southwest Iran. Iranian J Blood & Cancer. 2013;6(1):41-6.
Sadeghian MH, Keramati MR, Badiei Z, Ravarian M, Ayatollahi H, Rafatpanah H, Daluei MK. Alloimmunization among transfusion-dependent thalassemia patients. Asian J Transfus Sci. 2009 Jul;3(2):95.
Sci J Iran Blood Transfus Organ 2019;16(2): 82-90
Original Article
The prevalence of undesired blood group antibodies in Imam Khomeini Hospital Complex patients
1School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran 2Pediatric Congenital Hematologic Disorders Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran 3Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran 4Imam Khomeini Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran 5Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran 6School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
Abstract Background and Objectives
There are many antibodies and antigens that cause blood group related transfusion reactions. In this study we aim to find the prevalence of blood group antibodies in patients at different ages and with different gender.
Materials and Methods
In this descriptive study, we screened 30659 patients (59% female and 41% male, age range 1-85) referring to different wards of Imam Khomeini complex hospital during 2017-2018 for presence of any antibodies against blood group antigens. Then, for those patients with screened positive antibody we identified the antibody in each patient. Finally we categorized the antibody positive patients based on their main ABO and Rh blood group of all wards such as cancer, hematology, general and also separately for postpartum ward.
Results
Out of 30659 patients in all wards, 123 and out of 4364 just in postpartum ward, 20 patients had positive antibody. The most prevalent alloantibodies were detected to be anti-E(31.7%), anti-K(30.8%), and anti-D(14.6%) in order.
Conclusions
Anti-E and anti-K are the most likely antibodies presenting in patients with positive antibody screening results awareness of which can be helpful in storing blood components with rare blood groups. Moreover, the evaluation of common alloantibodies in the postpartum ward shows that the administration of RhoGAM might not be adequate in HDFN prevention and other antibodies should be considered in this regard.
Key words: Blood Group Incompatibility, Alloantibodies, Autoantibodies, Hemolytic Disease of Newborn, Transfusion Reaction
Received: 10 Apr 2019 Accepted: 22 May 2019
Correspondence: Mohammadimaram M.R., MSc of Hematology and Blood Banking. School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences.
Postal Code: 8491754683, Tehran, Iran. Tel: (+9831) 52642041; Fax : (+9831) 52642041
E-mail: Mohamadimaram1990@yahoo.com
Mohamadimaram M, Gharehbaghian A, Baghestani A, Vahidianfar B, Abdollahi A, Razani E et al . The prevalence of undesired blood group antibodies in Imam Khomeini Hospital Complex patients. Sci J Iran Blood Transfus Organ 2019; 16 (2) :82-90 URL: http://bloodjournal.ir/article-1-1262-en.html